nLIGHT, Inc. Announces Fourth Quarter and Full Year 2022 Results
nLIGHT, Inc. (NASDAQ: LASR) reported 2022 revenues of $242.1 million, down 10.4% from $270.1 million in 2021. The fourth quarter revenues were $56.7 million, a decrease of 16.0% year-over-year. Gross margins fell to 21.0% for the year and 10.2% for Q4, significantly lower than previous periods. The company incurred approximately $10 million in non-routine charges due to restructuring and inventory adjustments. nLIGHT anticipates Q1 2023 revenues between $50 million and $56 million, with a gross margin outlook of 17% to 20%.
- 21% growth in Industrial and Microfabrication revenues outside of China, reaching a record $133 million in 2022.
- Operational milestones achieved in Directed Energy, a key growth market.
- 2022 revenues down 10.4% from 2021.
- Net loss for 2022 escalated to $54.6 million compared to $29.7 million in 2021.
- Gross margin declined to 21.0% from 28.6% in 2021.
Revenues of
Revenues of
“Our performance in 2022 reflects the continuing evolution of our business. Strong execution of our strategic growth initiatives enabled us to achieve
Full Year 2022 Financial Highlights
|
Year Ended
|
|
|
|||||||
(In thousands, except percentages) |
|
2022 |
|
|
|
2021 |
|
|
% Change |
|
Revenues |
$ |
242,058 |
|
|
$ |
270,146 |
|
|
(10.4 |
)% |
Gross margin |
|
21.0 |
% |
|
|
28.6 |
% |
|
|
|
Loss from operations |
$ |
(55,102 |
) |
|
$ |
(30,217 |
) |
|
(82.4 |
)% |
Operating margin |
|
(22.8 |
)% |
|
|
(11.2 |
)% |
|
|
|
Net loss |
$ |
(54,579 |
) |
|
$ |
(29,669 |
) |
|
(84.0 |
)% |
Adjusted EBITDA(1) |
$ |
(8,754 |
) |
|
$ |
22,562 |
|
|
(138.8 |
)% |
Adjusted EBITDA, as a percentage of revenues |
|
(3.6 |
)% |
|
|
8.4 |
% |
|
|
|
(1) A reconciliation of the non-GAAP metrics presented here to the most directly comparable GAAP metric has been provided in the tables included at the end of this release. |
Revenues of
Fourth Quarter 2022 Financial Highlights
|
Three Months Ended
|
|
|
|||||||
(In thousands, except percentages) |
|
2022 |
|
|
|
2021 |
|
|
% Change |
|
Revenues |
$ |
56,679 |
|
|
$ |
67,453 |
|
|
(16.0 |
)% |
Gross margin |
|
10.2 |
% |
|
|
26.6 |
% |
|
|
|
Loss from operations |
$ |
(23,495 |
) |
|
$ |
(8,665 |
) |
|
(171.1 |
)% |
Operating margin |
|
(41.5 |
)% |
|
|
(12.8 |
)% |
|
|
|
Net loss |
$ |
(22,659 |
) |
|
$ |
(8,750 |
) |
|
(159.0 |
)% |
Adjusted EBITDA(1) |
$ |
(9,502 |
) |
|
$ |
3,071 |
|
|
(409.4 |
)% |
Adjusted EBITDA, as a percentage of revenues |
|
(16.8 |
)% |
|
|
4.6 |
% |
|
|
|
(1) A reconciliation of the non-GAAP information provided here to the most directly comparable GAAP metric has been provided in the financial statement tables included in this release. |
Revenues of
Outlook
For the first quarter of 2023, nLIGHT expects revenues to be in the range of
We have not reconciled our outlook for Adjusted EBITDA because unrealized and realized foreign exchange gains and losses cannot be reasonably calculated or predicted nor can the probable significance be determined at this time. Accordingly, a reconciliation is not available without unreasonable effort.
Investor Conference Call at
Parties interested in listening to nLIGHT’s quarterly conference call may do so by dialing 1-844-763-8274 (
Use of Non-GAAP Financial Results
In addition to
We define Adjusted EBITDA as net income (loss) adjusted for income tax expense (benefit), other non-operating income or expense, interest income or expense, depreciation and amortization, stock-based compensation, acquisition and integration-related costs, and other non-recurring items as determined by management, as applicable. We define non-GAAP net income (loss) as GAAP net income (loss) adjusted for stock-based compensation, amortization of purchased intangibles, acquisition and integration-related costs, and other non-recurring items as determined by management, as applicable. We define non-GAAP net income (loss) per share, basic and diluted, as non-GAAP net income (loss) divided by the weighted-average number of shares outstanding during the respective period plus the dilutive effect of any common stock equivalents during the period in the case of non-GAAP net income (loss) per share, diluted.
Tables presenting the reconciliation of net loss to Adjusted EBITDA, as well as the reconciliation of GAAP to non-GAAP net income (loss) and GAAP to non-GAAP net income (loss) per share, basic and diluted, are included at the end of this press release.
Safe Harbor Statement
Certain statements in this release are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Words such as “outlook,” “guidance,” “expects,” “intends,” “projects,” “plans,” “believes,” “estimates,” “targets,” “anticipates,” and similar expressions may identify these forward-looking statements. Examples of forward-looking statements include, but are not limited to, statements regarding expected revenues, gross margin, and Adjusted EBITDA, and our business strategy and ability to grow our business, as well as any other statement that does not directly relate to any historical or current fact. Forward-looking statements are based on our current expectations and assumptions, which may not prove to be accurate. These statements are not guarantees and are subject to risks, uncertainties and changes in circumstances that are difficult to predict. Many factors could cause actual results to differ materially and adversely from these forward-looking statements, including but not limited to our ability to compete successfully in the markets for our products; changes in the markets we serve or in the global economy; our ability to increase our volumes and decrease our costs to offset potential declines in the average selling prices of our products; rapid technological changes in the markets that we participate in; our ability to develop and maintain products that can achieve market acceptance; our ability to generate sufficient revenues to achieve or maintain profitability in the future; our high levels of fixed costs and inventory and their effect on our gross profits and results of operations if demand for our products declines or we maintain excess inventory levels; widespread health crises, such as the COVID-19 pandemic, and their effect on our business, financial condition, or results of operations; our manufacturing capacity and operations and their suitability for future levels of demand; our reliance on a small number of customers for a significant portion of our revenues; our ability to manage risks associated with international customers and operations; the effect of government export and import controls on our ability to compete in international markets; our ability to protect our proprietary technology and intellectual property rights; fluctuations in our quarterly results of operations and other operating measures; and the effect on our business of claims, lawsuits, government investigations, other legal or regulatory proceedings, or commercial or contractual disputes that we are or may become involved in. Additional information concerning these and other factors can be found in nLIGHT's filings with the
The nLIGHT logo and “nLIGHT” are registered trademarks or trademarks of
About nLIGHT
Consolidated Statements of Operations (In thousands, except per share data) (Unaudited) |
|||||||||||||||
|
Three Months Ended
|
|
Year Ended
|
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Revenue: |
|
|
|
|
|
|
|
||||||||
Products |
$ |
45,375 |
|
|
$ |
50,906 |
|
|
$ |
192,658 |
|
|
$ |
206,195 |
|
Development |
|
11,304 |
|
|
|
16,547 |
|
|
|
49,400 |
|
|
|
63,951 |
|
Total revenue |
|
56,679 |
|
|
|
67,453 |
|
|
|
242,058 |
|
|
|
270,146 |
|
Cost of revenue: |
|
|
|
|
|
|
|
||||||||
Products |
|
40,471 |
|
|
|
34,039 |
|
|
|
145,272 |
|
|
|
132,867 |
|
Development |
|
10,425 |
|
|
|
15,472 |
|
|
|
45,965 |
|
|
|
59,972 |
|
Total cost of revenue(1) |
|
50,896 |
|
|
|
49,511 |
|
|
|
191,237 |
|
|
|
192,839 |
|
Gross profit |
|
5,783 |
|
|
|
17,942 |
|
|
|
50,821 |
|
|
|
77,307 |
|
Operating expenses: |
|
|
|
|
|
|
|
||||||||
Research and development(1) |
|
13,558 |
|
|
|
13,984 |
|
|
|
53,773 |
|
|
|
54,814 |
|
Sales, general, and administrative(1) |
|
11,828 |
|
|
|
12,623 |
|
|
|
48,258 |
|
|
|
52,710 |
|
Restructuring |
|
3,892 |
|
|
|
— |
|
|
|
3,892 |
|
|
|
— |
|
Total operating expenses |
|
29,278 |
|
|
|
26,607 |
|
|
|
105,923 |
|
|
|
107,524 |
|
Loss from operations |
|
(23,495 |
) |
|
|
(8,665 |
) |
|
|
(55,102 |
) |
|
|
(30,217 |
) |
Other income (expense): |
|
|
|
|
|
|
|
||||||||
Interest income (expense), net |
|
291 |
|
|
|
(37 |
) |
|
|
529 |
|
|
|
(163 |
) |
Other income, net |
|
446 |
|
|
|
90 |
|
|
|
338 |
|
|
|
336 |
|
Loss before income taxes |
|
(22,758 |
) |
|
|
(8,612 |
) |
|
|
(54,235 |
) |
|
|
(30,044 |
) |
Income tax expense (benefit) |
|
(99 |
) |
|
|
138 |
|
|
|
344 |
|
|
|
(375 |
) |
Net loss |
$ |
(22,659 |
) |
|
$ |
(8,750 |
) |
|
$ |
(54,579 |
) |
|
$ |
(29,669 |
) |
Net loss per share, basic |
$ |
(0.50 |
) |
|
$ |
(0.20 |
) |
|
$ |
(1.23 |
) |
|
$ |
(0.70 |
) |
Net loss per share, diluted |
$ |
(0.50 |
) |
|
$ |
(0.20 |
) |
|
$ |
(1.23 |
) |
|
$ |
(0.70 |
) |
Shares used in per share calculations: |
|
|
|
|
|
|
|
||||||||
Basic |
|
45,039 |
|
|
|
43,277 |
|
|
|
44,436 |
|
|
|
42,142 |
|
Diluted |
|
45,039 |
|
|
|
43,277 |
|
|
|
44,436 |
|
|
|
42,142 |
|
(1) Includes stock-based compensation as follows: |
|
|
|
|
|
|
|
||||
|
Three Months Ended
|
|
Year Ended
|
||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||
Cost of revenues |
$ |
572 |
|
$ |
725 |
|
$ |
2,677 |
|
$ |
2,505 |
Research and development |
|
2,267 |
|
|
3,025 |
|
|
11,675 |
|
|
13,433 |
Sales, general, and administrative |
|
3,190 |
|
|
4,238 |
|
|
12,405 |
|
|
21,782 |
|
$ |
6,029 |
|
$ |
7,988 |
|
$ |
26,757 |
|
$ |
37,720 |
Condensed Consolidated Balance Sheets (In thousands) (Unaudited) |
|||||||
|
As of |
||||||
|
|
|
|
||||
Assets |
|
|
|
||||
Current assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
57,826 |
|
|
$ |
146,534 |
|
|
|
50,391 |
|
|
|
— |
|
Accounts receivable, net |
|
37,913 |
|
|
|
41,574 |
|
Inventory |
|
67,600 |
|
|
|
73,746 |
|
Prepaid expenses and other current assets |
|
17,026 |
|
|
|
15,350 |
|
Total current assets |
|
230,756 |
|
|
|
277,204 |
|
Restricted cash |
|
252 |
|
|
|
250 |
|
Lease right-of-use assets |
|
13,893 |
|
|
|
17,048 |
|
Property, plant and equipment, net |
|
60,693 |
|
|
|
56,101 |
|
Intangible assets, net |
|
4,041 |
|
|
|
6,698 |
|
|
|
12,376 |
|
|
|
12,420 |
|
Other assets, net |
|
7,222 |
|
|
|
3,897 |
|
Total assets |
$ |
329,233 |
|
|
$ |
373,618 |
|
|
|
|
|
||||
Liabilities and Stockholders’ Equity |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Accounts payable |
$ |
17,507 |
|
|
$ |
26,347 |
|
Accrued liabilities |
|
12,820 |
|
|
|
14,730 |
|
Deferred revenue |
|
1,407 |
|
|
|
1,629 |
|
Current portion of lease liabilities |
|
2,758 |
|
|
|
3,066 |
|
Total current liabilities |
|
34,492 |
|
|
|
45,772 |
|
Non-current income taxes payable |
|
6,699 |
|
|
|
7,149 |
|
Long-term lease liabilities |
|
12,852 |
|
|
|
14,612 |
|
Other long-term liabilities |
|
4,345 |
|
|
|
3,952 |
|
Total liabilities |
|
58,388 |
|
|
|
71,485 |
|
Stockholders' equity: |
|
|
|
||||
Common stock - par value |
|
16 |
|
|
|
15 |
|
Additional paid-in capital |
|
496,211 |
|
|
|
470,760 |
|
Accumulated other comprehensive loss |
|
(2,748 |
) |
|
|
(587 |
) |
Accumulated deficit |
|
(222,634 |
) |
|
|
(168,055 |
) |
Total stockholders’ equity |
|
270,845 |
|
|
|
302,133 |
|
Total liabilities and stockholders’ equity |
$ |
329,233 |
|
|
$ |
373,618 |
|
Consolidated Statements of Cash Flows (In thousands) (Unaudited) |
|||||||
|
Year Ended |
||||||
|
|
2022 |
|
|
|
2021 |
|
Cash flows from operating activities: |
|
|
|
||||
Net loss |
$ |
(54,579 |
) |
|
$ |
(29,669 |
) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
||||
Depreciation |
|
11,085 |
|
|
|
9,179 |
|
Amortization |
|
4,614 |
|
|
|
5,880 |
|
Reduction in carrying amount of right-of-use assets |
|
3,000 |
|
|
|
3,253 |
|
Provision for (recoveries of) losses on accounts receivable |
|
4 |
|
|
|
(70 |
) |
Stock-based compensation |
|
26,757 |
|
|
|
37,720 |
|
Deferred income taxes |
|
4 |
|
|
|
37 |
|
Loss on disposal of assets |
|
51 |
|
|
|
16 |
|
Non-cash restructuring charges |
|
2,758 |
|
|
|
— |
|
Changes in operating assets and liabilities: |
|
|
|
||||
Accounts receivable, net |
|
2,757 |
|
|
|
(9,509 |
) |
Inventory |
|
4,623 |
|
|
|
(18,994 |
) |
Prepaid expenses and other current assets |
|
(1,753 |
) |
|
|
(3,630 |
) |
Other assets, net |
|
(5,219 |
) |
|
|
(570 |
) |
Accounts payable |
|
(5,904 |
) |
|
|
3,463 |
|
Accrued and other long-term liabilities |
|
(577 |
) |
|
|
(199 |
) |
Deferred revenues |
|
(208 |
) |
|
|
(909 |
) |
Lease liabilities |
|
(1,942 |
) |
|
|
(2,934 |
) |
Non-current income taxes payable |
|
(13 |
) |
|
|
(507 |
) |
Net cash used in operating activities |
|
(14,542 |
) |
|
|
(7,443 |
) |
Cash flows from investing activities: |
|
|
|
||||
Acquisition of business, net of cash acquired |
|
(664 |
) |
|
|
(291 |
) |
Purchases of property, plant and equipment |
|
(21,388 |
) |
|
|
(19,317 |
) |
Acquisition of intangible assets and capitalization of patents |
|
(332 |
) |
|
|
(2,245 |
) |
Purchase of marketable securities |
|
(99,985 |
) |
|
|
— |
|
Proceeds from maturities and sales of marketable securities |
|
49,988 |
|
|
|
— |
|
Net cash used in investing activities |
|
(72,381 |
) |
|
|
(21,853 |
) |
Cash flows from financing activities: |
|
|
|
||||
Proceeds from public offerings, net of offering costs |
|
— |
|
|
|
82,354 |
|
Principal payments on term loan, debt and financing leases |
|
— |
|
|
|
(428 |
) |
Payment of contingent consideration related to acquisition |
|
— |
|
|
|
(326 |
) |
Proceeds from employee stock plan purchases |
|
2,358 |
|
|
|
1,603 |
|
Proceeds from stock option exercises |
|
1,197 |
|
|
|
1,145 |
|
Tax payments related to stock award issuances |
|
(4,861 |
) |
|
|
(10,606 |
) |
Net cash provided by (used in) financing activities |
|
(1,306 |
) |
|
|
73,742 |
|
Effect of exchange rate changes on cash |
|
(477 |
) |
|
|
(235 |
) |
Net increase (decrease) in cash, cash equivalents and restricted cash |
|
(88,706 |
) |
|
|
44,211 |
|
Cash, cash equivalents and restricted cash, beginning of period |
|
146,784 |
|
|
|
102,573 |
|
Cash, cash equivalents and restricted cash, end of period |
$ |
58,078 |
|
|
$ |
146,784 |
|
Supplemental disclosures: |
|
|
|
||||
Cash paid (received) for interest, net |
$ |
— |
|
|
$ |
117 |
|
Cash paid for income taxes |
|
442 |
|
|
|
526 |
|
Operating cash outflows from operating leases |
|
3,925 |
|
|
|
3,513 |
|
Right-of-use assets obtained in exchange for lease liabilities |
|
1,349 |
|
|
|
8,012 |
|
Accrued purchases of property, equipment and patents |
|
207 |
|
|
|
2,522 |
|
Reconciliation of GAAP Financial Metrics to Non-GAAP (In thousands, except per share data) (Unaudited) |
|||||||||||||||
Reconciliation of Net Loss to Adjusted EBITDA |
|||||||||||||||
|
Three Months Ended
|
|
Year Ended
|
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Net loss |
$ |
(22,659 |
) |
|
$ |
(8,750 |
) |
|
$ |
(54,579 |
) |
|
$ |
(29,669 |
) |
Income tax expense (benefit) |
|
(99 |
) |
|
|
138 |
|
|
|
344 |
|
|
|
(375 |
) |
Other income, net |
|
(446 |
) |
|
|
(90 |
) |
|
|
(338 |
) |
|
|
(336 |
) |
Interest (income) expense, net |
|
(291 |
) |
|
|
37 |
|
|
|
(529 |
) |
|
|
163 |
|
Depreciation and amortization |
|
4,072 |
|
|
|
3,748 |
|
|
|
15,699 |
|
|
|
15,059 |
|
Stock-based compensation |
|
6,029 |
|
|
|
7,988 |
|
|
|
26,757 |
|
|
|
37,720 |
|
Restructuring charges |
|
3,892 |
|
|
|
— |
|
|
|
3,892 |
|
|
|
— |
|
Adjusted EBITDA |
$ |
(9,502 |
) |
|
$ |
3,071 |
|
|
$ |
(8,754 |
) |
|
$ |
22,562 |
|
Reconciliation of GAAP to Non-GAAP Net Income (Loss), and GAAP to Non-GAAP Net Income (Loss) per Share, Basic and Diluted |
|||||||||||||||
|
Three Months Ended
|
|
Year Ended
|
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Net loss |
$ |
(22,659 |
) |
|
$ |
(8,750 |
) |
|
$ |
(54,579 |
) |
|
$ |
(29,669 |
) |
Add back: |
|
|
|
|
|
|
|
||||||||
Stock-based compensation(1) |
|
6,029 |
|
|
|
7,988 |
|
|
|
26,757 |
|
|
|
37,720 |
|
Amortization of purchased intangibles (1) |
|
435 |
|
|
|
518 |
|
|
|
1,674 |
|
|
|
2,671 |
|
Restructuring charges |
|
3,892 |
|
|
|
— |
|
|
|
3,892 |
|
|
|
— |
|
Non-GAAP net income (loss) |
|
(12,303 |
) |
|
|
(244 |
) |
|
|
(22,256 |
) |
|
|
10,722 |
|
|
|
|
|
|
|
|
|
||||||||
GAAP weighted-average shares outstanding |
|
45,039 |
|
|
|
43,277 |
|
|
|
44,436 |
|
|
|
42,142 |
|
Participating securities |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
699 |
|
Non-GAAP weighted-average number of shares, basic |
|
45,039 |
|
|
|
43,277 |
|
|
|
44,436 |
|
|
|
42,841 |
|
Dilutive effect of common stock equivalents |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
4,341 |
|
Non-GAAP weighted-average number of shares, diluted |
|
45,039 |
|
|
|
43,277 |
|
|
|
44,436 |
|
|
|
47,182 |
|
|
|
|
|
|
|
|
|
||||||||
Non-GAAP net income (loss) per share, basic |
$ |
(0.27 |
) |
|
$ |
(0.01 |
) |
|
$ |
(0.50 |
) |
|
$ |
0.25 |
|
Non-GAAP net income (loss) per share, diluted |
$ |
(0.27 |
) |
|
$ |
(0.01 |
) |
|
$ |
(0.50 |
) |
|
$ |
0.23 |
|
(1) There is no income tax effect related to the stock-based compensation and amortization of purchased intangibles adjustments due to the full valuation allowance in |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230223005845/en/
Chief Financial Officer
(360) 566-4460
joe.corso@nlight.net
Source:
FAQ
What were nLIGHT's revenues for 2022?
How did nLIGHT's fourth quarter 2022 performance compare to the previous year?
What is nLIGHT's outlook for Q1 2023?
What was the net loss for nLIGHT in 2022?